EWP
EDIT icon

Engrave Wealth Partners’s Editas Medicine EDIT Stock Holding History

Engrave Wealth Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-80
Closed -$2K – 166
2020
Q2 		$2K Hold
80
– – ﹤0.01% 394
2020
Q1 		$1K Buy
+80
New +$2.02K ﹤0.01% 383

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Engrave Wealth Partners's EDIT Position: Q3 2020 in Review

Engrave Wealth Partners sold out of Editas Medicine (EDIT) in Q3 2020, closing a stake of 80 shares — an estimated $2K sold.

Engrave Wealth Partners first reported a position in EDIT in Q1 2020 and held it in 2 quarters. The position peaked at $2K in Q2 2020. 239 funds tracked by Wall St. Rank hold EDIT as of Q3 2020.

  • Engrave Wealth Partners reported no remaining Editas Medicine position as of Q3 2020 after selling out during the quarter.
  • Engrave Wealth Partners sold 80 Editas Medicine shares in Q3 2020, an estimated $2K.
  • Engrave Wealth Partners first reported a position in Editas Medicine in Q1 2020 and held it in 2 quarters.
  • Engrave Wealth Partners's Editas Medicine position peaked at $2K in Q2 2020.
  • 239 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2020.

Based on Engrave Wealth Partners's 13F filing for Q3 2020, filed 8 Oct 2020.